Why I'm worry-free with this sturdy ASX 200 share for the next decade

The world is full of anxiety, but some stocks will allow you to turn down the noise.

| More on:
A man leans back with his hands behind his head and feet on his desk with a big smile on his face at his success.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's an anxious time for everyone at the moment.

Put aside investing for a second. 

Just as everyday consumers, we are dealing with 12 interest rate hikes in just over a year, inflation and job insecurity.

No wonder we're all a bit skittish.

A couple of months ago, the EY Global Wealth survey found that 58% of investors are now prioritising protection against capital loss and inflation. 

Forget making money, they just want to preserve what they have.

"Continued market stress is amplifying their defensive stance… as well as their appetite for both switching and adding to their portfolio," EY Oceania wealth and asset management leader Rita Da Silva said at the time.

So are there any S&P/ASX 200 Index (ASX: XJO) shares that you can just buy now and lock away for years, so you can switch off all the doom and gloom?

If you can stay loyal, this stock could reward you

One stock you could put away into the bottom drawer, in my opinion, is Xero Limited (ASX: XRO).

Remembering that past performance is no indicator of the future, the accounting software maker has ably demonstrated its resilience over the past two years.

Caught up in the market sentiment turning against growth and technology stocks, the Xero share price dropped more than 55% from November 2021 to November 2022.

But the New Zealand business, under a new chief executive, has since started reforming its strategy to reduce cash burn and focus more on earnings and profits.

Already it has borne fruit, with the ASX 200 share rocketing almost 80% year to date.

That leaves its five-year returns at an impressive 172%, even through the 2020 COVID-19 crash and the 2022 tech correction.

What that demonstrates is that Xero has the ability to adapt and grow, and provides reliable returns to investors who are willing to stick out short-term volatility.

Superior pricing power

What about inflation though?

The past year has shown that the demographics of Xero's clientele gives it superior pricing power, compared to ASX companies that serve end consumers.

Accounting software, once adopted by a business, is time-consuming and expensive to change. If they're happy with the product, then it will be too much hassle for a client to change to a rival.

This "stickiness" has allowed Xero to push through price rises in recent times without copping too much damage.

"Xero retains strong pricing power, given the structural tailwinds driving cloud accounting adoption globally, that can continue to mitigate any impact from weaker subscriber growth," said Fairmont Equities managing director Michael Gable back in April.

The Motley Fool's Tristan Harrison pointed out Xero's pricing power in May.

"In the company's FY23 half-year result, its average revenue per user (ARPU) increased by 13% to $35.30," he said.

"The business reported a 30% increase in operating revenue, while free cash flow jumped 145%."

Motley Fool contributor Tony Yoo has positions in Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »